• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滋肾育胎丸通过介导PI3K-Akt通路及卵巢细胞凋亡水平改善卵巢储备功能。

Zishen Yutai pill ameliorates ovarian reserve by mediating PI3K-Akt pathway and apoptosis level in ovary.

作者信息

Chen Jianzhao, Wang Nannan, Peng Zilun, Pang Xiufei, Ning Na, Du Qingyun, Guo Qiuping, Huang Qiuling

机构信息

Center for Drug Non-Clinical Evaluation and Research, Guangzhou General Pharmaceutical Research Institute Company Limited, Guangzhou, Guangdong, 510240, People's Republic of China.

Guangzhou Baiyunshan Zhongyi Pharmaceutical Company Limited, Guangzhou, Guangdong, 510530, People's Republic of China.

出版信息

J Ovarian Res. 2025 Mar 24;18(1):61. doi: 10.1186/s13048-025-01643-0.

DOI:10.1186/s13048-025-01643-0
PMID:40128862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11931746/
Abstract

Zishen Yutai Pill (ZYP) is a widely used Chinese patent medicine in the clinical treatment of diminished ovarian reserve (DOR) induced infertility in China. However, the pharmacological actions and underlying mechanisms of ZYP in treating DOR remain poorly understood. This study aimed to evaluate the therapeutic effects of ZYP on DOR and elucidate its potential mechanisms. Two models including tripterygium glycosides (TGs)-induced DOR rat model and pZP3-induced DOR mouse model were selected to assess the effectiveness of ZYP in treating DOR. The intervention lasted for 4 weeks in both models. ZYP administration significantly increased the primordial follicles and the serum levels of AMH both in DOR rat and mouse model. Further, ZYP regulated the apoptosis pathway and apoptosis-related molecules including PI3K-Akt signaling pathway, Bcl6 and Abtb2 in ovary of DOR rat. The ovarian apoptosis level was significantly downregulated in a dose-depended manner in ZYP groups. Thus, we demonstrate that ZYP improved the ovarian reserve in DOR models. The mechanisms of ZYP on DOR may be mediated through decreasing the apoptosis level by the regulation of PI3K-Akt signaling pathway and apoptosis molecules (Bcl6, Abtb2) in ovary.

摘要

滋肾育胎丸(ZYP)是中国临床上广泛用于治疗卵巢储备功能下降(DOR)所致不孕症的中成药。然而,ZYP治疗DOR的药理作用及潜在机制仍知之甚少。本研究旨在评估ZYP对DOR的治疗效果并阐明其潜在机制。选用雷公藤多苷(TGs)诱导的DOR大鼠模型和pZP3诱导的DOR小鼠模型来评估ZYP治疗DOR的有效性。两个模型的干预均持续4周。在DOR大鼠和小鼠模型中,给予ZYP均显著增加了原始卵泡数量和血清抗苗勒管激素(AMH)水平。此外,ZYP调节了DOR大鼠卵巢中的凋亡途径及凋亡相关分子,包括PI3K-Akt信号通路、Bcl6和Abtb2。ZYP组的卵巢凋亡水平以剂量依赖方式显著下调。因此,我们证明ZYP改善了DOR模型中的卵巢储备功能。ZYP治疗DOR的机制可能是通过调节卵巢中的PI3K-Akt信号通路和凋亡分子(Bcl6、Abtb2)来降低凋亡水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/15fad2cd7ec4/13048_2025_1643_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/88ce65ec18fe/13048_2025_1643_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/b27cb344ca34/13048_2025_1643_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/5f600bafb999/13048_2025_1643_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/597eb8360347/13048_2025_1643_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/825b18fe1c18/13048_2025_1643_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/65c921bc5b7c/13048_2025_1643_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/b262dea529ba/13048_2025_1643_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/279d5c788590/13048_2025_1643_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/00f3ea0c59ce/13048_2025_1643_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/15fad2cd7ec4/13048_2025_1643_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/88ce65ec18fe/13048_2025_1643_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/b27cb344ca34/13048_2025_1643_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/5f600bafb999/13048_2025_1643_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/597eb8360347/13048_2025_1643_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/825b18fe1c18/13048_2025_1643_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/65c921bc5b7c/13048_2025_1643_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/b262dea529ba/13048_2025_1643_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/279d5c788590/13048_2025_1643_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/00f3ea0c59ce/13048_2025_1643_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a30/11931746/15fad2cd7ec4/13048_2025_1643_Fig10_HTML.jpg

相似文献

1
Zishen Yutai pill ameliorates ovarian reserve by mediating PI3K-Akt pathway and apoptosis level in ovary.滋肾育胎丸通过介导PI3K-Akt通路及卵巢细胞凋亡水平改善卵巢储备功能。
J Ovarian Res. 2025 Mar 24;18(1):61. doi: 10.1186/s13048-025-01643-0.
2
Dingkun Pill replenishes diminished ovarian reserve through the PI3K/AKT/mTOR signaling pathway in TWP-induced mice.定坤丹通过 PI3K/AKT/mTOR 信号通路改善雷公藤多苷致卵巢储备功能下降模型小鼠的卵巢储备功能。
J Ethnopharmacol. 2020 Nov 15;262:112993. doi: 10.1016/j.jep.2020.112993. Epub 2020 May 28.
3
Zihuai recipe alleviates cyclophosphamide-induced diminished ovarian reserve via suppressing PI3K/AKT-mediated apoptosis.脂槐方通过抑制 PI3K/AKT 介导的细胞凋亡减轻环磷酰胺诱导的卵巢储备功能下降。
J Ethnopharmacol. 2021 Sep 15;277:113789. doi: 10.1016/j.jep.2021.113789. Epub 2021 Jan 7.
4
Moxibustion alleviates decreased ovarian reserve in rats by restoring the PI3K/AKT signaling pathway.艾灸通过恢复PI3K/AKT信号通路减轻大鼠卵巢储备功能下降。
J Integr Med. 2022 Mar;20(2):163-172. doi: 10.1016/j.joim.2022.01.007. Epub 2022 Jan 31.
5
Zishen Yutai pills restore fertility in premature ovarian failure through regulating arachidonic acid metabolism and the ATK pathway.紫参毓胎丸通过调节花生四烯酸代谢和ATK途径恢复卵巢早衰患者的生育能力。
J Ethnopharmacol. 2024 Apr 24;324:117782. doi: 10.1016/j.jep.2024.117782. Epub 2024 Jan 24.
6
Acupuncture Combined with Bushen-Jianpi Decoction Ameliorates the Ovarian Function of Diminished Ovarian Reserve Rats by Regulating Phosphoinositide 3-Kinase/AKT Signaling.针刺联合补肾健脾方通过调节磷酸肌醇 3-激酶/蛋白激酶 B 信号通路改善卵巢储备功能减退大鼠的卵巢功能。
Comb Chem High Throughput Screen. 2024;27(16):2402-2418. doi: 10.2174/0113862073264971231113061204.
7
Therapeutic importance of Zishen Yutai Pill on the female reproductive health: A review.滋肾育胎丸对女性生殖健康的治疗重要性:综述。
J Ethnopharmacol. 2021 Dec 5;281:114523. doi: 10.1016/j.jep.2021.114523. Epub 2021 Aug 24.
8
Investigation of the Mechanisms and Experimental Verification of Yulin Formula in the Treatment of Diminished Ovarian Reserve via Network Pharmacology.基于网络药理学探讨育麟方治疗卵巢储备功能减退的作用机制及实验验证。
Drug Des Devel Ther. 2023 Jul 24;17:2147-2163. doi: 10.2147/DDDT.S413142. eCollection 2023.
9
The chronic hepatotoxicity assessment of the herbal formula Zishen Yutai pill.中药制剂滋肾育胎丸的慢性肝毒性评估
Regul Toxicol Pharmacol. 2017 Feb;83:81-88. doi: 10.1016/j.yrtph.2016.12.001. Epub 2016 Dec 2.
10
Neutral effect of Zishen Yutai Pill on frozen-thawed embryo transfer: a propensity score matching study.滋肾育胎丸对冻融胚胎移植结局无影响:一项倾向性评分匹配研究。
Front Endocrinol (Lausanne). 2024 Aug 29;15:1379590. doi: 10.3389/fendo.2024.1379590. eCollection 2024.

引用本文的文献

1
Pharmacological Evaluation of Polygoni Multiflori Radix Praeparata Extract: Inhibition of PANoptosis in Alleviating Premature Ovarian Insufficiency.制何首乌提取物的药理学评价:抑制PAN凋亡以缓解卵巢早衰
Curr Issues Mol Biol. 2025 Jul 19;47(7):569. doi: 10.3390/cimb47070569.

本文引用的文献

1
The effects of growth hormone on the outcomes of fertilization and embryo transfer in age-grouped patients with decreased ovarian reserve: a prospective cohort study.生长激素对卵巢储备功能下降的不同年龄组患者受精及胚胎移植结局的影响:一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2025 Jan 14;15:1457866. doi: 10.3389/fendo.2024.1457866. eCollection 2024.
2
Chronic unpredictable stress induces anxiety-like behavior and oxidative stress, leading to diminished ovarian reserve.慢性不可预测应激会诱发焦虑样行为和氧化应激,导致卵巢储备功能下降。
Sci Rep. 2024 Dec 28;14(1):30681. doi: 10.1038/s41598-024-76717-y.
3
Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials.
卵巢储备功能减退女性的治疗管理:随机对照试验的系统评价和荟萃分析
Fertil Steril. 2025 Mar;123(3):457-476. doi: 10.1016/j.fertnstert.2024.09.038. Epub 2024 Sep 26.
4
Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.雄激素(脱氢表雄酮或睾酮)用于接受辅助生殖的女性。
Cochrane Database Syst Rev. 2024 Jun 5;6(6):CD009749. doi: 10.1002/14651858.CD009749.pub3.
5
Kuntai capsule for the treatment of diminished ovarian reserve: A systematic review and meta-analysis of randomized controlled trials.坤泰胶囊治疗卵巢储备功能减退:一项随机对照试验的系统评价和荟萃分析
J Ethnopharmacol. 2024 Jul 15;329:118167. doi: 10.1016/j.jep.2024.118167. Epub 2024 Apr 7.
6
Mechanism Research of DHEA Treatment Improving Diminished Ovarian Reserve by Attenuating the AMPK-SIRT1 Signaling and Mitophagy.脱氢表雄酮通过减弱AMPK-SIRT1信号通路和线粒体自噬改善卵巢储备功能下降的机制研究
Reprod Sci. 2024 Jul;31(7):2059-2072. doi: 10.1007/s43032-024-01473-3. Epub 2024 Mar 7.
7
Potential factors result in diminished ovarian reserve: a comprehensive review.潜在因素导致卵巢储备减少:综合评述。
J Ovarian Res. 2023 Oct 25;16(1):208. doi: 10.1186/s13048-023-01296-x.
8
Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis.脱氢表雄酮预处理对 IVF/ICSI 中卵巢反应不良女性的疗效:一项荟萃分析。
Front Endocrinol (Lausanne). 2023 Jun 9;14:1156280. doi: 10.3389/fendo.2023.1156280. eCollection 2023.
9
The Art of Hormone Replacement Therapy (HRT) in Menopause Management.《激素替代疗法(HRT)在更年期管理中的艺术》。
J Pharm Pract. 2024 Jun;37(3):736-740. doi: 10.1177/08971900231167925. Epub 2023 Apr 1.
10
Ovarian aging in humans: potential strategies for extending reproductive lifespan.人类卵巢衰老:延长生殖寿命的潜在策略。
Geroscience. 2023 Aug;45(4):2121-2133. doi: 10.1007/s11357-023-00768-8. Epub 2023 Mar 13.